1998EndocrinologyOpen access

Neuropeptide Y Lowers Blood Glucose in Anaesthetized Rats via a Y5 Receptor Subtype

Angela Bischoff

Open full text 7 citations

Abstract

We have investigated the receptor subtype mediating effects of neuropeptide Y (NPY) on blood glucose concentrations. In anaesthetized rats a 120 min i.v. infusion of 2 μg/kg/min NPY lowered blood glucose by 26 mg/dl. This was mimicked by the same dose of peptide YY (PYY), NPY2-36, PYY3-36 and[ Leu31,Pro34] NPY but not by NPY13-36, PYY13-36 or rat or human pancreatic polypeptide. The effects of NPY and[ Leu31,Pro34]NPY were not inhibited by 10μ g/kg/min BIBP 3226. Neither treatment significantly altered plasma insulin concentrations. We conclude that NPY lowers blood glucose concentrations via a Y5 receptor subtype, i.e. a subtype which has also been implicated in stimulation of food intake.

Open-access reader

About this research paper

What this paper is about

We have investigated the receptor subtype mediating effects of neuropeptide Y (NPY) on blood glucose concentrations. In anaesthetized rats a 120 min i.v. infusion of 2 μg/kg/min NPY lowered blood glucose by 26 mg/dl. This was mimicked by the same dose of peptide YY (PYY), NPY2-36, PYY3-36 and[ Leu31,Pro34] NPY but not by NPY13-36, PYY13-36 or rat or human pancreatic polypeptide. The effects of NPY and[ Leu31,Pro34]NPY were not inhibited by 10μ g/kg/min BIBP 3226. Neither treatment significantly altered plasma insulin concentrations. We conclude that NPY lowers blood glucose concentrations via a Y5 receptor subtype, i.e. a subtype which has also been implicated in stimulation of food intake.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We have investigated the receptor subtype mediating effects of neuropeptide Y (NPY) on blood glucose concentrations. In anaesthetized rats a 120 min i.v. infusion of 2 μg/kg/min NPY lowered blood glucose by 26 mg/dl. This was mimicked by the same dose of peptide YY (PYY), NPY2-36, PYY3-36 and[ Leu31,Pro34] NPY but not by NPY13-36, PYY13-36 or rat or human pancreatic polypeptide. The effects of NPY and[ Leu31,Pro34]NPY were not inhibited by 10μ g/kg/min BIBP 3226. Neither treatment significantly altered plasma insulin concentrations. We conclude that NPY lowers blood glucose concentrations via a Y5 receptor subtype, i.e. a subtype which has also been implicated in stimulation of food intake.

Key concepts: Endocrinology, Internal medicine, Neuropeptide Y receptor, Peptide YY, Pancreatic polypeptide, Receptor, Insulin, Stimulation

Related papers

Back to paper searchBrowse research topicsOriginal source
Neuropeptide Y Lowers Blood Glucose in Anaesthetized Rats via a Y5 Receptor Subtype — Research Paper | ScholarLens